EBRO 2017

ESMO-ESGO-ESTRO recommendations 2015

4 risk groups

Risk group

Histology

Adjuvant treatment

Low

Ia, G1-2, LVSI -ve None

Intermediate Ib, G1-2, LVSI -ve BT or none if <60

With LND

No LND

High- intermediate

Ib, G1-2, LVSI +ve Ia, G3

BT or none BT if G3 and LVSI - EBRT if LVSI+

LVSI must be unequivocally positive (not focal)

Colombo N. Radiother Oncol. 2015;117(3):559-81